Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
EMS has acquired Medley, a pharmacy generics business in Brazil, for $3.6 billion. EMS acquisitions expand its generics and biosimilars footprint through Medley’s portfolio of generic medicines and related manufacturing and commercial capabilities. The EMS acquires Medley acquisition supports a strategic pharmacy acquisition plan to build a pathway into the United States generic market after 2030. The platform acquisition is structured as a strategic acquisition and is categorized as healthcare M&A, with the deal announced at approximately R$3.6 billion and expected to close subject to customary conditions.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026